Earnings Call · Q2 FY2025·2025-02-12

Q2 25EPS +100.00%*·Rev n/aQ1 25EPS +55.88%·Rev n/aQ4 24EPS -82.22%·Rev n/aQ3 24EPS +18.75%·Rev n/a⚠ consensus missing

AYTU BIOPHARMA, INC AYTU

Robert Blum — Host / Investor Relations

Josh Disbrow — Chief Executive Officer

Ryan Selhorn — Chief Financial Officer

−0.7%1d on move date−1.8% vs SPY3d+0.7%5d−0.7%

Research tier

Behavioral profile computed for 3 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more AYTU calls or request research access.

More AYTU calls Browse calls Request research access